Jeremy G Chadwick Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Jeremy G Chadwick is Chief Operating Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 67,800 shares of KYMR, which is worth approximately $2.21 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 1,383 shares (Common Stock) at a price of $30.67 per share, resulting in proceeds of $42,416. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.8K
53.45% 3M change
45.0% 12M change
Total Value Held $2.21 Million

Jeremy G Chadwick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Open market or private sale
$42,416 $30.67 p/Share
1,383 Reduced 2.0%
67,800 Common Stock
Mar 03 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 26.54%
69,183 Common Stock
May 23 2024
SELL
Open market or private sale
$90,099 $34.99 p/Share
2,575 Reduced 5.51%
44,183 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
13,425 Added 22.31%
46,758 Common Stock
May 22 2023
BUY
Grant, award, or other acquisition
-
33,333 Added 50.0%
33,333 Common Stock
JGC

Jeremy G Chadwick

Chief Operating Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR